Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
117TH CONGRESS
1ST SESSION H. R. 3236
To prohibit the President from taking any action to support the waiver
of obligations of members of the World Trade Organization under the
Agreement on Trade-Related Aspects of Intellectual Property Rights
in relation to the prevention, containment, mitigation, or treatment of
COVID–19 unless a statute is enacted expressly authorizing such a
waiver with respect to the prevention, containment, mitigation, or treat-
ment of COVID–19, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
MAY 14, 2021
Ms. SALAZAR (for herself, Mr. RICE of South Carolina, Mr. DONALDS, Mr.
JACKSON, and Mr. BILIRAKIS) introduced the following bill; which was
referred to the Committee on Foreign Affairs, and in addition to the
Committee on Ways and Means, for a period to be subsequently deter-
mined by the Speaker, in each case for consideration of such provisions
as fall within the jurisdiction of the committee concerned
A BILL
To prohibit the President from taking any action to support
the waiver of obligations of members of the World Trade
Organization under the Agreement on Trade-Related As-
pects of Intellectual Property Rights in relation to the
prevention, containment, mitigation, or treatment of
COVID–19 unless a statute is enacted expressly author-
izing such a waiver with respect to the prevention, con-
tainment, mitigation, or treatment of COVID–19, and
for other purposes.
VerDate Sep 11 2014
20:32 Jun 17, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H3236.IH
H3236
lotter on DSK11XQN23PROD with BILLS
2
•HR 3236 IH
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘American Medical In-
4
vestment Generating Overseas Security Act’’ or the ‘‘AMI-
5
GOS Act’’.
6
SEC. 2. PROHIBITION ON ACTION TO SUPPORT WAIVER OF
7
OBLIGATIONS OF WTO MEMBERS UNDER THE
8
TRIPS AGREEMENT IN RELATION TO THE
9
PREVENTION, CONTAINMENT, MITIGATION,
10
OR TREATMENT OF COVID–19.
11
The President may not take any action to support
12
the waiver of obligations of members of the World Trade
13
Organization under the TRIPS Agreement to implement
14
or apply sections 1, 4, 5, and 7 of part II of the TRIPS
15
Agreement or to enforce such sections under part III of
16
the TRIPS Agreement in relation to the prevention, con-
17
tainment, mitigation, or treatment of COVID–19 unless
18
a statute is enacted expressly authorizing such a waiver
19
with respect to the prevention, containment, mitigation,
20
or treatment of COVID–19.
21
SEC. 3. PRIORITY IN ALLOCATING EXCESS VACCINES FOR
22
COVID–19 TO OTHER COUNTRIES.
23
(a) IN
GENERAL.—In allocating vaccines for
24
COVID–19 that are procured by or otherwise subject to
25
VerDate Sep 11 2014
20:32 Jun 17, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3236.IH
H3236
lotter on DSK11XQN23PROD with BILLS
3
•HR 3236 IH
the control of the Federal Government and in excess of
1
the demand for such vaccines by individuals in the United
2
States who are eligible to receive such vaccines, the Presi-
3
dent shall allocate such vaccines in accordance with the
4
following order of priority:
5
(1) First, to other countries in the Western
6
Hemisphere with the lowest rates of immunization
7
for COVID–19.
8
(2) Second, to other countries in the Western
9
Hemisphere based on other metrics developed by the
10
President.
11
(3) Third, to United States allies and partner
12
countries with the lowest rates of immunization for
13
COVID–19.
14
(4) Fourth, to United States allies and partner
15
countries based on the metrics developed under
16
paragraph (2).
17
(b) EXCEPTIONS.—In allocating vaccines described in
18
subsection (a), the President may waive the prioritization
19
otherwise required by such subsection to allocate such vac-
20
cines to countries that are determined by the President
21
to be—
22
(1) experiencing a significantly high number of
23
per capita COVID–19 cases and associated hos-
24
pitalizations;
25
VerDate Sep 11 2014
20:32 Jun 17, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3236.IH
H3236
lotter on DSK11XQN23PROD with BILLS
4
•HR 3236 IH
(2) at risk of a country-wide health care system
1
collapse as a result of COVID–19; or
2
(3) experiencing the spread of a variant of
3
SARS–CoV–2 that needs to be contained.
4
(c) MONITORING.—The President shall monitor the
5
allocation of vaccines for COVID–19 to foreign countries
6
under this section to ensure the governments of such coun-
7
tries provide such vaccines to the peoples of such countries
8
in a timely manner and do not otherwise withhold such
9
vaccines.
10
SEC. 4. MARKING REQUIREMENTS.
11
(a) IN GENERAL.—Except as provided in subsection
12
(b), vaccines for COVID–19 provided to foreign countries
13
under section 3 shall be marked as assistance from the
14
American people or the United States Government and
15
shall include a depiction of the flag of the United States
16
if appropriate.
17
(b) EXCEPTION.—The marking requirements of sub-
18
section (a) shall not apply if the President determines that
19
such requirements will endanger the lives or safety of per-
20
sons delivering such vaccines or would have an adverse ef-
21
fect on the administration of such vaccines.
22
SEC. 5. DEFINITIONS.
23
In this Act:
24
VerDate Sep 11 2014
20:32 Jun 17, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3236.IH
H3236
lotter on DSK11XQN23PROD with BILLS
5
•HR 3236 IH
(1) COVID–19.—The term ‘‘COVID–19’’ re-
1
fers to the 2019 coronavirus disease caused by
2
SARS–CoV–2.
3
(2) SARS–CoV–2.—The term ‘‘SARS–CoV–2’’
4
refers to the severe acute respiratory syndrome
5
coronavirus 2 virus responsible for COVID–19 and
6
includes any viral variant mutating therefrom with
7
pandemic potential.
8
(3) TRIPS AGREEMENT.—The term ‘‘TRIPS
9
Agreement’’ means the Agreement on Trade-Related
10
Aspects of Intellectual Property Rights referred to in
11
section 101(d)(15) of the Uruguay Round Agree-
12
ments Act (19 U.S.C. 3511(d)(15)).
13
Æ
VerDate Sep 11 2014
20:32 Jun 17, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H3236.IH
H3236
lotter on DSK11XQN23PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.